A Case of Herpes Zoster and Meningitis in a Twice-Vaccinated Healthy Adolescent

Abstract

Since the adoption of the varicella-zoster virus (VZV) vaccine, the incidence of varicella infections of all types has declined. Although uncommon, local cutaneous herpes zoster secondary to vaccine-strain VZV has been well documented in healthy children. However, there are few reports of vaccine-strain VZV central nervous system disease in this same population. We present a case of a previously healthy twice-VZV vaccinated 14-year-old girl who presented with rash and headache who was found to have herpes zoster complicated by meningitis. Cerebrospinal fluid polymerase chain reaction confirmed zoster infection secondary to reactivation of vaccine-strain VZV. Her disease course and response to therapy are reviewed.

Keywords

varicella-zoster virus vaccine - varicella-zoster virus - herpes zoster - meningitis

^* These authors contributed equally to this work.

• References

• 1 American Academy of Pediatrics Committee on Infectious Diseases. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007; 120 (1) 221-231
• 2 Galea SA, Sweet A, Beninger P , et al. The safety profile of varicella vaccine: a 10-year review. J Infect Dis 2008; 197 (Suppl. 02) S165-S169
• 3 Civen R, Chaves SS, Jumaan A , et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009; 28 (11) 954-959
• 4 Chaves SS, Haber P, Walton K , et al. Safety of varicella vaccine after licensure in the United States: experience from reports to the vaccine adverse event reporting system, 1995-2005. J Infect Dis 2008; 197 (Suppl. 02) S170-S177
• 5 Han JY, Hanson DC, Way SS. Herpes zoster and meningitis due to reactivation of varicella vaccine virus in an immunocompetent child. Pediatr Infect Dis J 2011; 30 (3) 266-268
• 6 Iyer S, Mittal MK, Hodinka RL. Herpes zoster and meningitis resulting from reactivation of varicella vaccine virus in an immunocompetent child. Ann Emerg Med 2009; 53 (6) 792-795
• 7 Pahud BA, Glaser CA, Dekker CL, Arvin AM, Schmid DS. Varicella zoster disease of the central nervous system: epidemiological, clinical, and laboratory features 10 years after the introduction of the varicella vaccine. J Infect Dis 2011; 203 (3) 316-323
• 8 Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E. Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 2013; 17 (7) e529-e534
• 9 Tunkel AR, Glaser CA, Bloch KC , et al; Infectious Diseases Society of America. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008; 47 (3) 303-327
• 10 Smith JP, Weller S, Johnson B, Nicotera J, Luther JM, Haas DW. Pharmacokinetics of acyclovir and its metabolites in cerebrospinal fluid and systemic circulation after administration of high-dose valacyclovir in subjects with normal and impaired renal function. Antimicrob Agents Chemother 2010; 54 (3) 1146-1151